14882-94-1

Usage

Uses

Used in Pharmaceutical Applications:
Rutamarin is used as a therapeutic agent for its potential anti-cancer properties, where it may contribute to the inhibition of tumor growth and progression. It is also utilized for its anti-inflammatory effects, which can be beneficial in managing inflammation-related conditions.
Used in Nutraceutical Applications:
Rutamarin is used as a dietary supplement for its antioxidant properties, supporting overall health by combating oxidative stress and potentially reducing the risk of various diseases.
Used in Cardiovascular Health Applications:
Rutamarin is used as a cardiovascular health promoter, potentially reducing the risk of stroke and other cardiovascular diseases by supporting healthy blood flow and pressure.
Used in Antiviral Applications:
Rutamarin is used as an antiviral agent, potentially inhibiting the replication and spread of certain viruses, thereby contributing to the prevention and treatment of viral infections.
Used in Neurodegenerative Disorder Treatment:
Rutamarin is used as a neuroprotective agent in the treatment of neurodegenerative disorders, potentially slowing down disease progression and improving neurological function.
Each application of rutamarin leverages its unique bioactive properties, making it a versatile compound with potential therapeutic applications across various health conditions.

InChI:InChI=1/C21H24O5/c1-7-20(3,4)15-9-13-8-14-10-18(21(5,6)26-12(2)22)24-16(14)11-17(13)25-19(15)23/h7-9,11,18H,1,10H2,2-6H3/t18-/m0/s1

Upstream product

• 13164-04-0 2,3-dihydro-2-(2-hydroxypropan-2-yl)-6-(2-methylbut-3-en-2-yl)furo[3,2-g]chromen-7-one 
• 108-24-7 acetic anhydride 
• 1111-97-3 3-chloro-3-methylbut-1-yne 
• 65763-00-0 7-hydroxy-8-iodocoumarin 
• 1242260-99-6 4-benzyloxy-2-(3-methylbut-2-enyloxy)benzaldehyde 
• 1242261-00-2 C₂₇H₃₄O₅ 
• 1242261-01-3 7-benzyloxy-6-(3-methylbut-2-enyl)-3-(2-methylbut-3-en-2-yl)-2H-chromen-2-one 
• 95-01-2 2,4-Dihydroxybenzaldehyde 
• 52085-14-0 4-benzoxy-salicylaldehyde 
• 112699-35-1 8-iododemethylsuberosin acetate 
• 112723-61-2 6-(3',3'-dimethylallyl)-7-(3'',3''-dimethylallyloxy)-8-iodocoumarin 
• 112699-37-3 8-iododemethylsuberosin 
• 104311-20-8 7-(1',1'-dimethylallyloxy)-8-iodocoumarin 
• 77712-80-2 7-O-(1,1-dimethyl-2-propynyl)-8-iodo-2H-1-benzopyran-2-one 

Relevant academic research and scientific papers

Improved total synthesis of racemic rutamarin

An improved, convenient and cost-effective process, using 2,4-dihydroxybenzaldehyde 2 as starting material for (±)-rutamarin 1, is described. The overall yield of 1 is 44% in eight steps, requiring no chromatographic purification. The Japan Institute of Heterocyclic Chemistry.

SYNTHESIS OF 3-(1',1'-DIMETHYLALLYL)COUMARINS: GRAVELLIFERONE, CHALEPIN AND RUTAMARIN

The 3-(1',1'-dimethylallyl)coumarins chalepin (2), rutamarin (3) and gravelliferone (4) have been synthesized from umbelliferon (7) via Claisen and Cope rearrangements of 3',3'-dimethylallyl ethers of 6-(3',3'-dimethylallyl)umbelliferon with and without an iodine atom as blocking group at C-8.